Global Cancer Biomarkers Market—Estimated to reach USD 17.2 billion by 2021

29 Jun

According to the report “Global Cancer Biomarkers Market,” published by Market Data Forecast, the global market is projected to reach USD 17.2 billion by 2021 from USD 10.35 billion in 2016, at a CAGR of 11.45% from 2016 to 2021.

According to the National Cancer Institute, a biomarker is “a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease,”(NCI) such as cancer. Biomarkers typically differentiate an affected patient from a person without the disease. The alterations can be due to a number of factors, including germline or somatic mutations, transcriptional changes, and post-translational modifications. There is tremendous variety of biomarkers, which can include proteins (e.g., an enzyme or receptor), nucleic acids (e.g., a microRNA or other non-coding RNA), antibodies, and peptides, among other categories. A biomarker can also be a collection of alterations, such as gene expression, proteomic, and metabolomic signatures. Biomarkers can be detected in the circulation (whole blood, serum, or plasma) or excretions or secretions (stool, urine, sputum, or nipple discharge), and thus easily assessed non-invasively and serially, or can be tissue-derived, and require either biopsy or special imaging for evaluation. Genetic biomarkers can be inherited, and detected as sequence variations in germ line DNA isolated from whole blood, sputum, or buccal cells, or can be somatic, and identified as mutations in DNA derived from tumor tissue.

Get a comprehensive overview of the Global Cancer Biomarkers market:

Global Cancer Biomarkers Market: Drivers & Restraints
Key driving factors for the market are rationalized drug delivery procedure, non invasive technology, augmented rates of survival. Boost in government and private funding for oncology also fuels the market growth. Market is constrained by high cost of diagnosis, issues associated to reimbursement and some of the regulatory policies which hamper the market growth.

Get accurate market forecast and analysis on the Global Cancer Biomarkers market. Request a sample to stay up-to-date on the main trends affecting this market

Global Cancer Biomarkers market: Segmentation
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Cervical Cancer
- Other Cancers

- Sample Preparation
- Assay development
- Biomarkers validation and testing
- Risk Assessment
- Development of molecular diagnostics
- Disease diagnosis
- Drug discovery
- Development and Drug formulation

- Protein Biomarkers
- Genetic biomarkers
- genetic biomarkers

Profiling Technologies
- Omics technologies
- Genomics
- Proteomics
- Metabolomics
- Transcriptomics
- Pharmacogenomics
- Imaging technologies
- Immunoassays
- Cytogenetics
- Bioinformatics
- 5.5.6 IVD multivariate index assays

From simple data collation through secondary and primary research toad-hoc research requests relating to specific information, we provide our services via customization. Get customization at

Global Cancer Biomarkers market: Overview
Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the introduction of technologically advanced companion diagnostic kits is estimated to provide the market with high growth potential. Increasing awareness about personalized medicines amongst patients is further anticipated to boost adoption of cancer biomarkers.

In addition, presence of favorable government initiatives for the development of novel cancer diagnostic techniques is a key factor for market growth. For instance, the National Cancer Institute (NCI) provides funding to more than 8 research areas pertaining to cancer biomarker development. Cancer Research UK, Lung Cancer Research Foundation, and National Institutes of Health are some of the organizations providing funding for biomarker research.

People with high alcohol consumption, tobacco usage, unhealthy food habits, and sedentary lifestyle are reported to be 80% more at risk of developing cancer as compared to other individuals. Infections such as Human papillomavirus (HPV), Epstein-Barr virus, Hepatitis B virus, and Helicobacter pylori are also been studied to be related in cancer development.

Global Cancer Biomarkers market: Region-wise Outlook
Based on geography, the market is analysed under various regions namely, North America, Latin America, Europe, Asia-Pacific and Middle-East & Africa. The Asia-Pacific market is poised to record the highest growth rate in the forecast period due to the supporting government funding for cancer biomarker research, increasing prevalence of cancer, rising demand for advanced healthcare facilities in developing economies such as India and China, growing number of clinical trials, and rising focus of international players in emerging markets.

Key Questions Answered
- What is the current and future Cancer Biomarkers market outlook worldwide? What trends are affecting the Global market?
- What is the competitive landscape and market share of major players in the Ovarian Cancer Biomarkers space globally?
- What are the key, high growth markets that Cancer Biomarkers manufacturers should expand into? Which market segments are growing the fastest?
- What are the unmet needs with the Cancer Biomarkers currently on the market? How will emerging technologies fulfil these unmet needs?
- What is physician perception and market outlook of Cancer Biomarkers?
- What are the challenges and barriers that have hindered widespread adoption of Cancer Biomarkers?

Global Cancer Biomarkers market: Key Players
Some of the major players in this market are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A., Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Clarient Inc, Diadexus Inc, Ambrilia Biopharma, Affymetrix Inc and Aureon Laboratories Inc.

Reasons to buy Cancer Biomarkers market Report:
-Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
- Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
-Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
-Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
-A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
-Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
-Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Molecular Diagnostics Segment:

Biomarkers Market:

About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit,

Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @
View latest Press Releases of MDF @